Reporting of Palliative Sedation and Use of Opioids at the End of Life in a Belgian University Hospital: A Pilot Study

被引:3
|
作者
Marechal, Nicolas [1 ]
Six, Stefaan [2 ,3 ]
Clemmen, Eveline [4 ]
Baillon, Catherine [4 ]
Tack, Annelien [4 ]
Bauwens, Sabien [4 ]
Noppen, Marc [5 ]
Distelmans, Willem [4 ]
Beyer, Ingo [1 ]
Bilsen, Johan [2 ,3 ]
机构
[1] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Dept Geriatr, Brussels, Belgium
[2] Vrije Univ Brussel, Dept Publ Hlth, Mental Hlth, Brussels, Belgium
[3] Vrije Univ Brussel, Wellbeing Res Grp, Brussels, Belgium
[4] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Dept Support & Palliat Care, Brussels, Belgium
[5] Univ Ziekenhuis Brussel, Vrije Univ Brussel, Board Directors, Brussels, Belgium
关键词
end-of-life decisions; in-hospital mortality; opioids; palliative care; physician intention; CONTINUOUS DEEP SEDATION; EUTHANASIA; CARE;
D O I
10.1089/jpm.2021.0113
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Palliative sedation requires no formal registration in Belgium. For euthanasia, however, there are clear guidelines in certain countries, including mandatory registration and evaluation of cases. Official guidelines have been developed for palliative sedation, but research still shows unskilled use of sedation and unclear demarcation between palliative sedation and euthanasia. Registration could be used to avoid unskilled use of sedation and to avoid use or abuse of sedation to hasten the patient's death (described as "slow/passive euthanasia"). Objective: To evaluate the current practice of palliative sedation and use of opioids and sedatives at the end of life by using a registration document. Design: Retrospective observational study. Setting/Subjects: We included all in-hospital deaths at an academic hospital in Belgium of patients (age >= 18 years) who had received parenteral opioids, benzodiazepines, barbiturates, or other anesthetics during the last 24 hours. Measurements: We investigated indications for palliative sedation, patients' and physicians' characteristics, types of medication used, and the decision-making process with the patients and family. The questionnaires were collected between July 9 and November 25, 2016. The study was approved by the Biomedical Ethics Committee of UZ Brussel (B.U.N. 1432016293). Results: In a population of 124 patients, refractory symptoms were reported in 94.4%. All patients received parenteral opioids (intravenously). Benzodiazepines were used in 51.6%. In 75.8%, physicians reported no change in treatment plan during end of life. Hastening death by increasing analgesics and/or sedatives was mentioned in 19.3%. The treatment plan was discussed with patients in 26.6% of cases. In 6 cases, an explicit intention to hasten death was mentioned; in 36 cases, doses of opioids/sedatives may not have been strictly proportional to symptoms. Conclusion: This Belgian study shows that objective reporting of palliative sedation can be used as a tool to ensure good clinical practice where patients receive the most appropriate end-of-life care, avoiding abusive and injudicious or unskilled use of sedation.
引用
收藏
页码:742 / 748
页数:7
相关论文
共 50 条
  • [41] Palliative Sedation in COVID-19 End-of-Life Care. Retrospective Cohort Study
    Ramos-Rincon, Jose-Manuel
    Moreno-Perez, Oscar
    Gomez-Martinez, Nazaret
    Priego-Valladares, Manuel
    Climent-Grana, Eduardo
    Marti-Pastor, Ana
    Portilla-Sogorb, Joaquin
    Sanchez-Martinez, Rosario
    Merino, Esperanza
    MEDICINA-LITHUANIA, 2021, 57 (09):
  • [42] Palliative Sedation at the End of Life: A Comparative Study of Chronic Obstructive Pulmonary Disease and Lung Cancer Patients
    Tejero, Elena
    Pardo, Paloma
    Sanchez-Sanchez, Sonia
    Galera, Raul
    Casitas, Raquel
    Martinez-Ceron, Elisabet
    Garcia-Rio, Francisco
    RESPIRATION, 2021, 100 (01) : 1 - 10
  • [43] The Use of Opioids in the Last Week of Life in an Acute Palliative Care Unit
    Mercadante, Sebastiano
    Ferrera, Patrizia
    Casuccio, Alessandra
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2010, 277 (08) : 514 - 517
  • [44] Palliative Care Intervention for Choice and Use of Opioids in the Last Hours of Life
    Bailey, F. Amos
    Ferguson, Laura
    Williams, Beverly R.
    Woodby, Lesa L.
    Redden, David T.
    Durham, Rosie M.
    Goode, Patricia S.
    Burgio, Kathryn L.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2008, 63 (09): : 974 - 978
  • [45] Changing Practices in the Use of Continuous Sedation at the End of Life: A Systematic Review of the Literature
    Heijltjes, Madelon T.
    van Thiel, Ghislaine J. M. W.
    Rietjens, Judith A. C.
    van der Heide, Agnes
    de Graeff, Alexander
    van Delden, Johannes J. M.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2020, 60 (04) : 828 - +
  • [46] The use of palliative care by people of Islamic faith and their preferences and decisions at the end of life: A scoping review
    Al Shhadat, Ibrahim
    Wobst, Lisa-Maria
    Meyer, Gabriele
    Makhmutov, Rustem
    Fleischer, Steffen
    PALLIATIVE & SUPPORTIVE CARE, 2025, 23
  • [47] Organizing end of life in hospital palliative care: A Canadian example
    Krawczyk, Marian
    SOCIAL SCIENCE & MEDICINE, 2021, 291
  • [48] Use of the Palliative Performance Scale (PPS) for End-of-Life Prognostication in a Palliative Medicine Consultation Service
    Lau, Francis
    Maida, Vincent
    Downing, Michael
    Lesperance, Mary
    Karlson, Nicholas
    Kuziemsky, Craig
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2009, 37 (06) : 965 - 972
  • [49] Hub and Spokes-Implementation of Basic Palliative Care into University Hospital Practice-A Pilot Study
    Hertler, Caroline
    Feuz, Markus
    Schettle, Markus
    Theile, Gudrun
    Blum, David
    JOURNAL OF PALLIATIVE MEDICINE, 2024, 27 (07) : 926 - 929
  • [50] Palliative Sedation: Further Evidence Needs to Be Accompanied by Ethical Guidance to Ensure Professional Practice at the End of Life Reply
    Maltoni, Marco
    Scarpi, Emanuela
    Rosati, Marta
    Derni, Stefania
    Fabbri, Laura
    Martini, Francesca
    Amadori, Dino
    Nanni, Oriana
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (33) : 4177 - 4178